CFTR and breast carcinoma: In an attempt to evaluate interaction between CFTR and hyaluronan transmembrane transport, we synthesized a new class of drug-like compounds (Hylout4) that mimic the non-reducing end of hyaluronan and discovered that they activated chloride export from bronchial epithelial cells and hyaluronan export from breast cancer cells [9].